Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy

Clinical trial NCT00542997 · COMPLETED

Trial details

NCT number: NCT00542997
Sponsor: CSL Behring
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Common Variable Immunodeficiency X-linked Agammaglobulinemia Autosomal Recessive Agammaglobulinemia

Start date: 2007-09-01
Primary completion: 2009-08-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.